Persons who suffer from intractable seizures are safer if attended when seizures strike. Consequently, there is a need for wearable devices capable of detecting both convulsive and nonconvulsive seizures in everyday life. We have developed a three-stage seizure detection methodology based on 339 h of data (26 seizures) collected from 10 patients in an epilepsy monitoring unit. Our intent is to develop a wearable system that will detect seizures, alert a caregiver and record the time of seizure in an electronic diary for the patient's physician. Stage I looks for concurrent activity in heart rate, arterial oxygenation and electrodermal activity, all of which can be monitored by a wrist-worn device and which in combination produce a very low false positive rate. Stage II looks for a specific pattern created by these three biosignals. For the patients whose seizures cannot be detected by Stage II, Stage III detects seizures using limited-channel electroencephalogram (EEG) monitoring with at most three electrodes. Out of 10 patients, Stage I recognized all 11 seizures from seven patients, Stage II detected all 10 seizures from six patients and Stage III detected all of the seizures of two out of the three patients it analyzed.

No abstract

No abstract

No abstract

Wearable biosensors have become increasingly popular in healthcare due to their capabilities for low cost and long term biosignal monitoring. This paper presents a novel two-stage technique to offer biometric identification using these biosensors through Deep Belief Networks and Restricted Boltzman Machines. Our identification approach improves robustness in current monitoring procedures within clinical, e-health and fitness environments using Photoplethysmography (PPG) signals through deep learning classification models. The approach is tested on TROIKA dataset using 10-fold cross validation and achieved an accuracy of 96.1%.

No abstract

No abstract

No abstract